Senti Biosciences Holdings Inc (SNTI)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Senti Biosciences Holdings Inc-Aktie (SNTI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	0.89% 16.95	16.80	16.40	16.17	15.21
Operating Income/Loss	0.89% -16.95	-16.80	-16.40	-16.17	-15.21
Nonoperating Income/Loss	157.05% -1.178	2.065	2.285	15.56	-13.65
Income/Loss From Continuing Operations Before Tax	23.03% -18.13	-14.73	-14.11	-0.61	-28.87
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	23.03% -18.13	-14.73	-14.11	-0.61	-28.87
Net Income/Loss	23.03% -18.13	-14.73	-14.11	-0.61	-28.87
Preferred Stock Dividends And Other Adjustments	-	-	-	2.522	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.56% 26.23	26.08	10.01	0.0226	4.5771
Diluted Average Shares	0.56% 26.23	26.08	10.01	0.0226	4.5771
Basic Earnings Per Share	23.21% -0.69	-0.56	-1.41	-0.62	-6.31
Diluted Earnings Per Share	23.21% -0.69	-0.56	-1.41	-0.62	-6.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	2.522	-